Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Arcadia Biosciences Inc (NASDAQ: RKDA) was $1.98 for the day, up 8.79% from the previous closing price of $1.82. In other words, the price has increased by $8.79 from its previous closing price. On the day, 51913.0 shares were traded. RKDA stock price reached its highest trading level at $1.98 during the session, while it also had its lowest trading level at $1.82.
Ratios:
Our analysis of RKDA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.03 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for this company, H.C. Wainwright on August 17, 2020, Reiterated its Buy rating but revised its target price to $12 from $14 previously.
On June 09, 2015, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.Piper Jaffray initiated its Overweight rating on June 09, 2015, with a $10 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 03 ’25 when Kawakami Mark bought 700 shares for $2.49 per share. The transaction valued at 1,743 led to the insider holds 2,681 shares of the business.
Schaefer Thomas J. bought 700 shares of RKDA for $1,743 on Feb 03 ’25. The Chief Executive Officer now owns 2,819 shares after completing the transaction at $2.49 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RKDA now has a Market Capitalization of 2718777 and an Enterprise Value of -3166222. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.53 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at -0.612 whereas that against EBITDA is 0.532.
Stock Price History:
The Beta on a monthly basis for RKDA is 0.55, which has changed by -0.70114946 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, RKDA has reached a high of $6.71, while it has fallen to a 52-week low of $1.76. The 50-Day Moving Average of the stock is -44.50%, while the 200-Day Moving Average is calculated to be -48.88%.
Shares Statistics:
RKDA traded an average of 539.87K shares per day over the past three months and 29720 shares per day over the past ten days. A total of 1.37M shares are outstanding, with a floating share count of 1.36M. Insiders hold about 0.82% of the company’s shares, while institutions hold 4.77% stake in the company. Shares short for RKDA as of 1765756800 were 41927 with a Short Ratio of 0.08, compared to 1763078400 on 94939. Therefore, it implies a Short% of Shares Outstanding of 41927 and a Short% of Float of 3.06.
